Ambea AB (CHIX:AMBEAS) YoY EBITDA Growth: 23.38% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:AMBEAS Ambea AB CHIX:AMBEAS
83 GF Score
Price kr144.20
GF Value kr108.64
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Ambea AB YoY EBITDA Growth?

Ambea AB CHIX:AMBEAS 83 YoY EBITDA Growth is 23.38% as of Jun. 2026. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 83/100 and a GF Value™ of kr108.64 (Modestly Overvalued). The stock has 9 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ambea AB's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 23.38%.

Ambea AB's EBITDA per Share for the three months ended in Jun. 2026 was kr9.48.

Ambea AB YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Ambea AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambea AB YoY EBITDA Growth Chart

Ambea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.45 24.58 17.84 21.20 11.56

Ambea AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.85 18.01 4.61 27.88 23.38
CHIX:AMBEAS
83GF Score
Ambea AB CHIX:AMBEAS
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambea AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ambea AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(33.906-30.393)/ | 30.393 |
=11.56 %

Ambea AB's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(9.482-7.685)/ | 7.685 |
=23.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 23.38% mean?
Ambea AB (CHIX:AMBEAS) has a YoY EBITDA Growth of 23.38% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ambea AB and its competitors.
Is Ambea AB's YoY EBITDA Growth too high?
Ambea AB's current YoY EBITDA Growth is 23.38%. Overall, Ambea AB has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's YoY EBITDA Growth compare to HCA and THC?
Ambea AB's YoY EBITDA Growth of 23.38% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ambea AB and its competitors. Ambea AB's current YoY EBITDA Growth is 23.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr108.64, compared to a current price of kr144.20 — trading 32.7% above its estimated fair value. The current YoY EBITDA Growth is 23.38%. Ambea AB's overall GF Score™ is 83/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current YoY EBITDA Growth is 23.38% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?

Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued. The current stock price of kr144.20 is trading 32.7% above its estimated GF Value™ of kr108.64. GuruFocus considers Ambea AB to be Modestly Overvalued.

Key valuation signals for CHIX:AMBEAS:

  • YoY EBITDA Growth: 23.38%
  • GF Value™: kr108.64 vs. price of kr144.20 (32.7% above fair value)
  • GF Score™: 83/100 with 9 warning signs

No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambea AB Business Description

Address Rontgenvagen 3D, Box 1565, Solna, Stockholm, SWE, 171 29
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
83GF Score

Get the complete analysis for CHIX:AMBEAS

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr144.20
Price
kr108.64
GF Value